Transaktionen anzeigen
Private Equity | Gesundheitswesen

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Ace Pharmaceuticals is a leading pharmaceutical company in the niche of medical need products, and is based in Zeewolde, the Netherlands. As an independent company, Ace focuses on the development, production and distribution of licensed and unlicensed medicines. With its activities, Ace meets an essential social need: making and keeping scarce medication available for people for whom it is essential. It does so by actively collaborating with relevant stakeholders, including patient associations, doctors and governmental institutions. Since January 2020, Ace has also been supplying pharmaceutical compounding products to pharmacies in the Netherlands through its business unit Ace Compounding.

Oaklins’ debt advisory team in the Netherlands acted as advisor to the consortium and assisted in establishing a financing package aligned with the current business profile and future growth ambitions.

DIENSTLEISTUNG
Beschaffung von Kapital
PARTEIEN
«The COVID-19 pandemic has clearly highlighted the challenges and gaps in our industry in Europe. It makes our mission to make scarce medicines available more important than ever. We want to respond to this situation strongly by growing organically as well as through acquisitions in Europe. With the capital, the know-how and the broad (international) network of Gilde Buy Out Partners, Gilde Healthcare, and our existing investor Quadrum Capital, we can achieve this in both a socially responsible as well as financially sound manner.»

Jan Willem Popma

Director, Ace Pharmaceuticals BV

Sprechen Sie mit dem Deal Team

 Bas  Stoetzer

Bas Stoetzer

Partner
Amsterdam, Niederlande
Oaklins Netherlands
 Niels  Vermuë

Niels Vermuë

Senior Associate
Amsterdam, Niederlande
Oaklins Netherlands

Transaktionen

SulAmérica and Rede D’Or São Luiz have announced a combination
Finanzdienstleistungen | Gesundheitswesen

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Mehr erfahren
Brookdale Treeland Nurseries has sold a majority stake to Rouge River Capital
Private Equity | Landwirtschaft

Brookdale Treeland Nurseries has sold a majority stake to Rouge River Capital

The shareholders of Brookdale Treeland Nurseries have sold a controlling stake to Rouge River Capital.

Mehr erfahren
Laboratoire Dazont has been acquired by SBM Company
Gesundheitswesen

Laboratoire Dazont has been acquired by SBM Company

The shareholders of Laboratoire Dazont have sold the company to SBM Company.

Mehr erfahren